The underlying reason for higher levels of TgAb in DTC patients with lymph node metastasis may be that advanced tumors can elicit a stronger immune response within the thyroid or lymph nodes, leading to enhanced expression of Tg or an increased capacity to induce the production of TgAb (24). Here, TG is linked to metastatic malignant neoplasm in the lymph nodes.